Literature DB >> 30644534

Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti-inflammatory action.

Guang Yang1, Jingyu Wang1, Shengsheng Lu1, Zhao Chen1, Sheng Fan1, Daiwei Chen1, Huanxin Xue1, Wenyuan Shi2, Jian He1.   

Abstract

BACKGROUND AND
PURPOSE: Propionibacterium acnes (P. acnes) is a Gram-positive bacterium associated with the skin disorder acne. In this study, we determined the importance of fatty acids in the life habitat of P. acnes; we tested our lipopeptide library in an attempt to create potent P. acnes-specific antimicrobial agents. EXPERIMENTAL APPROACH: Antimicrobial activity was determined by the minimal inhibitory concentration (MIC). Lipids from P. acnes were used to explore the mode of action. RAW264.7 cells respectively stimulated with LPS and P. acnes were used to measure the anti-inflammatory activity. Mice ears injected with P. acnes were used to assess the antimicrobial and anti-inflammatory effects of the peptides tested in vivo. KEY
RESULTS: The most potent candidate, C16-KWKW, was observed to be more active against P. acnes, with an MIC of 2 μg·ml-1 , than against other non-targeted bacterial strains, such as Streptococcus mutans, Staphylococcus aureus, and Escherichia coli. The mode of action of C16-KWKW was observed to be through interference with the integrity of bacterial membrane, thereby impairing membrane permeability and causing leakage of the inner contents of bacterial cells. In addition, C16-KWKW inhibited the expression of pro-inflammatory cytokines, such as IL-1β, TNF-α, and inducible NOS, stimulated by both LPS and P. acnes, thus showing potential anti-inflammatory activity, which was further assessed in animal studies in vivo. CONCLUSIONS AND IMPLICATIONS: C16-KWKW is a lipopeptide displaying both anti-P. acnes and anti-inflammatory effects in vitro and in vivo, and exhibits potential as a treatment for acne vulgaris induced by P. acnes.
© 2019 The British Pharmacological Society.

Entities:  

Year:  2019        PMID: 30644534      PMCID: PMC6514292          DOI: 10.1111/bph.14571

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

1.  Narrow-spectrum antibiotics are as effective as broad-spectrum antibiotics in the treatment of community-acquired pneumonia.

Authors:  Anna Selby; Katrina Pettit; Nick Brown
Journal:  Arch Dis Child Educ Pract Ed       Date:  2015-06-30       Impact factor: 1.309

Review 2.  Interactions of Antimicrobial Peptides with Bacterial Membranes and Membrane Components.

Authors:  Martin Malmsten
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

3.  The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.

Authors:  Ahmad Arouri; Margitta Dathe; Alfred Blume
Journal:  Biophys Chem       Date:  2013-05-24       Impact factor: 2.352

4.  The novel antibacterial peptide ceratotoxin A alters permeability of the inner and outer membrane of Escherichia coli K-12.

Authors:  L Marri; R Dallai; D Marchini
Journal:  Curr Microbiol       Date:  1996-07       Impact factor: 2.188

5.  Tuning the antimicrobial pharmacophore to enable discovery of short lipopeptides with multiple modes of action.

Authors:  Yuxin Fang; Wenjing Zhong; Yue Wang; Tianrong Xun; Dongguo Lin; Wenjun Liu; Jingyu Wang; Lin Lv; Shuwen Liu; Jian He
Journal:  Eur J Med Chem       Date:  2014-06-04       Impact factor: 6.514

6.  Extractable and non-extractable polyphenols from blueberries modulate LPS-induced expression of iNOS and COX-2 in RAW264.7 macrophages via the NF-κB signalling pathway.

Authors:  Anwei Cheng; Caijing Han; Xixiu Fang; Jinyue Sun; Xiangyan Chen; Fachun Wan
Journal:  J Sci Food Agric       Date:  2015-12-29       Impact factor: 3.638

7.  Rapid probing of biological surfaces with a sparse-matrix peptide library.

Authors:  Daniel K Yarbrough; Randal Eckert; Jian He; Elizabeth Hagerman; Fengxia Qi; Renate Lux; Ben Wu; Maxwell H Anderson; Wenyuan Shi
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

8.  Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.

Authors:  Scott N Dean; Barney M Bishop; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2011-05-23       Impact factor: 3.605

9.  Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.

Authors:  Christina Katanov; Shalom Lerrer; Yulia Liubomirski; Leonor Leider-Trejo; Tsipi Meshel; Jair Bar; Rotem Feniger-Barish; Iris Kamer; Gali Soria-Artzi; Hadar Kahani; Debabrata Banerjee; Adit Ben-Baruch
Journal:  Stem Cell Res Ther       Date:  2015-05-01       Impact factor: 6.832

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

View more
  2 in total

1.  Retracted: Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti-inflammatory action, by G Yang, J Wang, S Lu, et al. British Journal of Pharmacology, volume 176(11): 1603-1618, published in May 2019: DOI 10.1111/bph.14571.

Authors: 
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

2.  Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti-inflammatory action.

Authors:  Guang Yang; Jingyu Wang; Shengsheng Lu; Zhao Chen; Sheng Fan; Daiwei Chen; Huanxin Xue; Wenyuan Shi; Jian He
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.